titanium has been researched along with Heart Diseases in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, H; Han, Z; Shu, J | 1 |
Karjalainen, PP; Kervinen, K; Lalmand, J; Mikkelsson, J; Nammas, W; Pentikäinen, M; Pietilä, M; Rivero-Crespo, F; Romppanen, H; Tedjokusumo, P | 1 |
Cho, YK; Han, JR; Lee, WS; Park, YS; Sunkara, V | 1 |
Chen, S; Chen, Z; Jia, G; Luan, X; Wang, H; Wang, Y; Zhao, L; Zhuo, L | 1 |
Airaksinen, JK; Karjalainen, PP; Laine, M; Nammas, W; Niemelä, M; Ylitalo, A | 1 |
Abukabda, AB; Hathaway, QA; Hollander, JM; McBride, CR; McLaughlin, SL; Nichols, CE; Nurkiewicz, TR; Pinti, MV; Rellick, SL; Shepherd, DL; Stapleton, PA; Stine, SM; Stricker, JC; Yi, J | 1 |
Ellis, ED; Girardi, DJ; Phillips, JA; Tankersley, WG; Watkins, JP | 1 |
7 other study(ies) available for titanium and Heart Diseases
Article | Year |
---|---|
Highly chemiluminescent TiO
Topics: Biomarkers; Energy Transfer; Glycopeptides; Heart Diseases; Humans; Luminescence; Luminol; Metal Nanoparticles; Titanium | 2019 |
Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Coated Materials, Biocompatible; Combined Modality Therapy; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Heart Diseases; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Sirolimus; Titanium; Treatment Outcome | 2013 |
Electrospun TiO2 nanofiber integrated lab-on-a-disc for ultrasensitive protein detection from whole blood.
Topics: Biomarkers; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Heart Diseases; Humans; Lab-On-A-Chip Devices; Nanofibers; Titanium; Troponin I | 2015 |
Effect of titanium dioxide nanoparticles on the cardiovascular system after oral administration.
Topics: Administration, Oral; Animals; Blood Pressure; Cytokines; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Heart Diseases; Heart Rate; Male; Metal Nanoparticles; Rats; Rats, Sprague-Dawley; Titanium | 2015 |
Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Case-Control Studies; Coronary Restenosis; Dilatation; Drug-Eluting Stents; Everolimus; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Stents; Titanium | 2017 |
Maternal-engineered nanomaterial exposure disrupts progeny cardiac function and bioenergetics.
Topics: Aging; Animals; Echocardiography; Electron Transport Complex I; Electron Transport Complex IV; Energy Metabolism; Female; Heart; Heart Diseases; Heart Function Tests; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Nanostructures; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Titanium | 2017 |
Occupational exposure and mortality among workers at three titanium dioxide plants.
Topics: Adult; Aged; Air Pollutants, Occupational; Cause of Death; Chemical Industry; Delaware; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Mississippi; Models, Statistical; Neoplasms; Occupational Diseases; Occupational Exposure; Poisson Distribution; Regression Analysis; Respiratory Tract Diseases; Tennessee; Time Factors; Titanium | 2013 |